(Q38355679)

2 September 2017

Potent and selective inhibition of gene expression by an antisense heptanucleotide (English)

1 reference

2 September 2017

Wagner RW

1

1 reference

2 September 2017

Matteucci MD

2

1 reference

2 September 2017

Grant D

3

1 reference

2 September 2017

Huang T

4

1 reference

2 September 2017

Froehler BC

5

1 reference

2 September 2017

language of work or name

1 reference

1 July 1996

1 reference

2 September 2017

1 reference

2 September 2017

14

1 reference

2 September 2017

840-844

1 reference

2 September 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt0796-840

2 September 2017

0 references

cites work

Gene inhibition using antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

Complementary large loops determine the rate of RNA duplex formation in vitro in the case of an effective antisense RNA directed against the human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Implication of RNA structure on antisense oligonucleotide hybridization kinetics

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Inhibition of human immunodeficiency virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev-response element stem-loop V.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

A more efficient and specific strategy in the ablation of mRNA in Xenopus laevis using mixtures of antisense oligos

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Antisense and Antigene Properties of Peptide Nucleic Acids

1 reference

https://api.crossref.org/works/10.1038%2FNBT0796-840

7 January 2021

Identifiers

DOI

10.1038/NBT0796-840

1 reference

2 September 2017

1 reference